Prediction, page-21

The B Cell platform (i.e. vaccinations) could potentially be used in the preventative space… and as the saying goes, prevention is better than cure. So, there’s potentially a market for both no matter what.

However, I posted an article recently that gave a bit of an explanation of how the immune system works which helped me understand why combo treatments are the way to go… and given the B Cell platform could potentially replace all existing monoclonal antibody treatments, it’s just as likely CF33 will be used in combo with B Cell to give a much better likelihood of a positive outcome.